Bavarian Nordic and Serum Institute of India Expand Strategic Partnership with Chikungunya Vaccine Manufacturing Agreement
- In tech
- Mar 11, 2026, 07:30 AM
- By Bavarian Nordic A/S
- 0 Views

COPENHAGEN, Denmark, March 11, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced an expansion of the strategic partnership with Serum Institute of India Pvt. Ltd. (SII) to include a contract manufacturing agreement covering a full tech transfer of the ma…
- The agreement enables a full tech transfer of the chikungunya vaccine for future supply to low- and middle-income countries.
- Expanded collaboration provides future co-development oppo… [+5040 chars]
- tech
- Mar 30, 2026, 06:32 AM
- tech
- Mar 30, 2026, 06:16 AM
- tech
- Mar 30, 2026, 12:30 AM
- tech
- Mar 29, 2026, 07:34 PM
- tech
- Mar 29, 2026, 07:34 PM
- tech
- Mar 29, 2026, 07:32 PM
- tech
- Mar 29, 2026, 07:30 PM
- tech
- Mar 29, 2026, 02:30 PM
- tech
- Mar 29, 2026, 02:30 PM
- tech
- Mar 29, 2026, 02:28 PM